Loading…
Omnicell, Inc. is projected to rise to $59.23 by 2027, a +32% move from its current price of $44.92. OMCL is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/13/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 14 | $44.05 | $44.96 | $45.88 | +0.08% |
| Jul 15 | $43.71 | $44.99 | $46.31 | +0.16% |
| Jul 16 | $43.47 | $45.03 | $46.65 | +0.24% |
| Jul 17 | $43.26 | $45.07 | $46.94 | +0.32% |
| Jul 18 | $43.09 | $45.10 | $47.21 | +0.41% |
| Jul 19 | $42.94 | $45.14 | $47.45 | +0.49% |
| Jul 20 | $42.80 | $45.18 | $47.68 | +0.57% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $42.80 | $45.18 | $47.68 | +0.57% |
| Week 2 | $42.09 | $45.43 | $49.03 | +1.14% |
| Week 3 | $41.61 | $45.69 | $50.17 | +1.71% |
| Week 4 | $41.25 | $45.95 | $51.19 | +2.29% |
| Week 5 | $40.96 | $46.21 | $52.14 | +2.87% |
| Week 6 | $40.72 | $46.47 | $53.04 | +3.46% |
| Week 7 | $40.52 | $46.74 | $53.91 | +4.04% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Omnicell, Inc. provides healthcare technology in the United States and internationally. It offers hospital and health systems solutions, such as points of care for clinician workflows in patient care areas of the healthcare system; Titan XT, an automated dispensing system; XTExtend, a console swap for its XT cabinets; and Central Pharmacy Dispensing Service for the medication dispensing process.
The company also provides Central Med Automation Service for medication dispensing; IV Compounding Service, an in-house compounding system; specialty pharmacy services, including turnkey solution to help health systems establish, manage, and optimize an entity-owned specialty pharmacy; EnlivenHealth platform to digitally enable retail and community pharmacies; medication adherence solutions comprising consumables and medication packaging systems; and technology implementation, customer education and training, program management, and related offerings to professional services.
In addition, it offers post-installation support and maintenance via phone and/or web, on-site service, parts, and access to software upgrades; software and hardware products for full traceability of medicines and medical supplies throughout the healthcare system; OmniSphere, a cloud-based platform. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc.
in 2001. Omnicell, Inc. was incorporated in 1992 and is headquartered in Fort Worth, Texas.
Omnicell, Inc. (OMCL) is a healthcare technology company. The current price is $45.24 and the market cap is $2.06B. It is currently ranked 1999.
Forecasts show a rising price path from 2026 through 2050, with 2026 avg $45.24 and max $63.93; 2027 avg $59.98; 2028 avg $68.17; 2029 avg $73.55; 2030 avg $76.37.
The sentiment shifts to BULLISH from 2027 onward, with rising ROIs: 2027 32.6%, 2028 50.7%, 2029 62.6%, 2030 68.8%, and the path continues to 2040 (368.6% ROI) and 2050 (815.2% ROI).
These figures are estimates and not guarantees.
A major floor 28.0% below — a decisive break under it would weaken the trend.
The nearest floor, 15.8% below — buyers have tended to step in here.
Price is pressing into resistance (1.5% away) — a breakout level to watch.
A major ceiling 12.5% above — clearing it would confirm fresh momentum.
Key OMCL support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of OMCL market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $45.05 | Sell | $44.63 | Buy |
| MA 10 | $43.28 | Buy | $43.55 | Buy |
| MA 20 | $41.10 | Buy | $42.45 | Buy |
| MA 50 | $42.29 | Buy | $41.51 | Buy |
| MA 100 | $39.69 | Buy | $40.74 | Buy |
| MA 200 | $39.44 | Buy | $39.45 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 63.00 | Neutral |
| Stoch RSI (14) | 81.94 | Sell |
| CCI (20) | 111.14 | Buy |
| Williams %R (14) | -9.33 | Info |
| MACD (12,26,9) | 0.65 | Buy |
| ROC (12) | 16.95 | Buy |
| Bollinger %B (20,2) | 0.86 | Neutral |
| Stochastic %K (14) | 90.67 | Sell |
| TRIX (15) | 0.09 | Buy |
| Awesome (5,34) | 3.26 | Buy |
| Ultimate (7,14,28) | 73.36 | Sell |
| Momentum (10) | 5.39 | Buy |
| Aroon Osc (25) | 72.00 | Buy |
| Hull MA (9) | 45.98 | Sell |
| ADX (14) | 19.80 | Neutral |
| ATR (14) | 0.83 | Info |
The 30-day technical picture is BULLISH. RSI14 is 70, indicating solid momentum, with SMA50 at $41.83 and SMA200 at $39.17.
The price is $45.24, facing resistance at $45.24 and support at $37.82. The 30-day range runs from $39.13 to $52.31.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $32.35 | $44.92 | $62.43 | 0% | Neutral | |
| $48.27 | $59.23 | $76.17 | +32% | Bullish | |
| $53.46 | $66.95 | $88.61 | +49% | Bullish | |
| $56.29 | $71.69 | $97.04 | +60% | Bullish | |
| $57.92 | $74.85 | $103.27 | +67% | Bullish | |
| $64.39 | $84.31 | $118.30 | +88% | Bullish | |
| $76.05 | $100.82 | $143.61 | +124% | Bullish | |
| $87.28 | $117.04 | $169.03 | +161% | Bullish | |
| $90.54 | $122.74 | $179.51 | +173% | Bullish | |
| $93.71 | $128.36 | $189.95 | +186% | Bullish | |
| $140.58 | $201.69 | $313.71 | +349% | Bullish | |
| $250.55 | $388.44 | $650.32 | +765% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $32.35 | $44.92 | $53.35 | +0.00% |
| August 2026 | $39.71 | $46.54 | $55.77 | +3.60% |
| September 2026 | $41.04 | $48.36 | $58.44 | +3.91% |
| October 2026 | $41.02 | $48.55 | $59.10 | +0.40% |
| November 2026 | $41.03 | $48.74 | $59.68 | +0.39% |
| December 2026 | $42.53 | $50.70 | $62.43 | +4.02% |
Click any year to see its month-by-month OMCL forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
The OMCL price prediction for 2026 points to an average of $44.92 (low $32.35, high $62.43) — a potential gain of 0% on today's $44.92. Price action looks broadly range-bound.
In 2027, OMCL is projected to trade between $48.27 and $76.17, averaging $59.23 — a potential gain of +32% from today's $44.92. That is up +32% on the projected 2026 average. Buyers look set to stay in control over this stretch.
Omnicell, Inc.'s 2028 outlook centres on $66.95, within a $53.46 to $88.61 range. That is up +13% on the projected 2027 average. That marks a +49% change versus current levels. Momentum favours further upside here.
By 2029, OMCL could reach as high as $97.04, with a base case around $71.69 and support toward $56.29 — roughly +60% from $44.92. Buyers look set to stay in control over this stretch.
Expect OMCL to range from $57.92 to $103.27 through 2030. The $74.85 average target implies a +67% move from current prices. That is up +4% on the projected 2029 average. Momentum favours further upside here.
The OMCL price prediction for 2031 points to an average of $84.31 (low $64.39, high $118.30) — a potential gain of +88% on today's $44.92. Buyers look set to stay in control over this stretch.
In 2032, OMCL is projected to trade between $76.05 and $143.61, averaging $100.82 — a potential gain of +124% from today's $44.92. That is up +20% on the projected 2031 average. Momentum favours further upside here.
Omnicell, Inc.'s 2033 outlook centres on $117.04, within a $87.28 to $169.03 range. That is up +16% on the projected 2032 average. That marks a +161% change versus current levels. Buyers look set to stay in control over this stretch.
By 2034, OMCL could reach as high as $179.51, with a base case around $122.74 and support toward $90.54 — roughly +173% from $44.92. Momentum favours further upside here.
Expect OMCL to range from $93.71 to $189.95 through 2035. The $128.36 average target implies a +186% move from current prices. That is up +5% on the projected 2034 average. Buyers look set to stay in control over this stretch.
The OMCL price prediction for 2040 points to an average of $201.69 (low $140.58, high $313.71) — a potential gain of +349% on today's $44.92. Momentum favours further upside here.
In 2050, OMCL is projected to trade between $250.55 and $650.32, averaging $388.44 — a potential gain of +765% from today's $44.92. That is up +93% on the projected 2040 average. Buyers look set to stay in control over this stretch.
Investing $1,000 in OMCL today (≈ 22.261799 OMCL) could be worth
$8,647.27
+$7,647.27 (+765%) by 2050 · US Dollar
Based on the average projected OMCL price of $388.44 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in OMCLwould be worth at today's price.
$1,000 invested in OMCL on Jul 10, 2025 (≈ 33.590863 OMCL) would be worth
$1,508.9
+$508.9 (+50.9%) today · 1.51× · US Dollar
Based on a OMCL entry price of $29.77 vs. today's $44.92.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $43.03 | $1,043.92 | +4.4% |
| 1 month ago | $38.18 | $1,176.53 | +17.7% |
| 3 months ago | $34.4 | $1,305.81 | +30.6% |
| 6 months ago | $51.19 | $877.52 | -12.2% |
| 1 year ago | $29.77 | $1,508.9 | +50.9% |
| All time (5.0y) ago | $152.13 | $295.27 | -70.5% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our OMCL forecast.
Our base-case forecast reaches $90.00 around 2032.
Implied market cap at $90.00: $4.09B
The multi-year forecast shows a rising path for Omnicell. In 2026, min $32.35, avg $45.24, max $63.93, with ROI 0 and sentiment NEUTRAL.
By 2030, the avg price is $76.37 with ROI 68.8% and bullish sentiment. By 2040, the avg price is $211.98 with ROI 368.6%; by 2050, the avg price is $414.05 with ROI 815.2% and bullish sentiment.
Overall, the forecasts project sustained upside into 2030, 2040, and 2050, but these are estimates, not guarantees.
Tap a question to reveal the answer.
In 2030, the forecasted avg price is $76.37, with a min of $58.50 and a max of $106.75, ROI 68.8%, sentiment bullish.
Forecasts show sentiment Neutral in 2026 and Bullish from 2027 onward; 2030 avg $76.37 with ROI 68.8%; 2040 avg $211.98 with ROI 368.6%; 2050 avg $414.05 with ROI 815.2%.
Yes. The 2030 max is $106.75, which is above 100.
The 2026 min $32.35, avg $45.24, max $63.93; sentiment NEUTRAL; 30-day technicals are bullish with RSI 70, price $45.24, resistance $45.24, and support $37.82.
Current price $45.24; market cap $2.06B.
Omnicell, Inc. Community Discussion
0Share your Omnicell, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.